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Background. Polymerase chain reaction (PCR) is extensively applied in gene cloning. But due to the existence of introns, low
copy number of particular genes and high complexity of the eukaryotic genome, it is usually impossible to amplify and clone
a gene as a full-length sequence directly from the genome by ordinary PCR based techniques. Cloning of cDNA instead of
genomic DNA involves multiple steps: harvest of tissues that express the gene of interest, RNA isolation, cDNA synthesis
(reverse transcription), and PCR amplification. To simplify the cloning procedures and avoid the problems caused by
ubiquitously distributed durable RNases, we have developed a novel strategy allowing the cloning of any cDNA or open
reading frame (ORF) with wild type sequence in any spliced form from a single genomic DNA preparation. Methodology. Our
‘‘Genomic DNA Splicing’’ technique contains the following steps: first, all exons of the gene are amplified from a genomic DNA
preparation, using software-optimized, highly efficient primers residing in flanking introns. Next, the tissue-specific exon
sequences are assembled into one full-length sequence by overlapping PCR with deliberately designed primers located at the
splicing sites. Finally, software-optimized outmost primers are exploited for efficient amplification of the assembled full-length
products. Conclusions. The ‘‘Genomic DNA Splicing’’ protocol avoids RNA preparation and reverse transcription steps, and the
entire assembly process can be finished within hours. Since genomic DNA is more stable than RNA, it may be a more practical
cloning strategy for many genes, especially the ones that are very large and difficult to generate a full length cDNA using
oligo-dT primed reverse transcription. With this technique, we successfully cloned the full-length wild type coding sequence of
human polymeric immunoglobulin receptor, which is 2295 bp in length and composed of 10 exons.
Citation: An X, Lu J, Huang J, Zhang B, Liu D, et al (2007) Rapid Assembly of Multiple-Exon cDNA Directly from Genomic DNA. PLoS ONE 2(11): e1179.
doi:10.1371/journal.pone.0001179
INTRODUCTION
Gene cloning is one of the most frequently used technologies in
a molecular biology laboratory. To study a particular gene, the first
step is usually to clone and express it. However, most of the
eukaryotic genes are interrupted by intervening sequences (introns),
which make the gene of interest very large. Manipulation of the large
genomic DNA is tedious and problematic due to size capacity of
cloning vectors and multiple restriction endonucleases which make it
difficult to find appropriate enzymes for subcloning. To circumvent
these difficulties, the cDNA is often used instead of its large genomic
counterpart. But cDNA cloning is usually troublesome, which
involves mRNA preparation and reverse transcription, and thus
requires RNA extraction kits and reverse transcription kits. For
a particular cDNA cloning, a specific tissue with a relatively high
level expression is often needed for the mRNA or total RNA
extraction. Some of these tissues are quite rare and difficult to obtain,
and some of the genes only have a very low level expression.
Furthermore, RNases are ubiquitously expressed in tissues and
RNase products are commonly used in molecular biology protocols
(such as plasmid DNA preparation). Since RNases are very stable
and difficult to remove completely, extra care must be taken when
working with RNA. Lastly, RNAs are unstable polynucleotides and
thus present their own problems in handling and storage.
As the genomic DNA sequence and annotation databases
skyrocketed in recent years, it has become easier to obtain
information on virtually any gene and the corresponding protein
sequence. With the advanced technology and low cost of
oligonucleotide synthesis, de novo gene synthesis is becoming
a common gene cloning option. Several gene synthesis strategies
have been developed over the past three decades, including
oligonucleotide ligation [1–3], the FokI method of gene synthe-
sis[4,5], self-priming PCR [6–8], dual asymmetric PCR[9],
combined dual asymmetric PCR and overlap extension PCR [10],
assembly PCR [11–13] and successive PCR [14–16]. Assembly PCR
was originally adopted in DNA shuffling for in vitro evolution of DNA
molecules [17,18]. With assembly PCR or successive PCR, any
DNA sequence can be easily obtained de novo by assembling synthetic
oligonucleotides. This technique makes DNA cloning very simple
and is applied widely and extensively in molecular biology studies.
To help design the assembly primers, as well as to optimize codon
usage for various expression systems, some dedicated computer
software [19] and internet online tools [12,20] have been developed.
Here we report a novel PCR-based in vitro genomic DNA
splicing strategy (designated as ‘‘PCR mediated Genomic DNA
Splicing’’ or GDS strategy) for cloning of any eukaryotic cDNA or
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coding sequence from a genomic DNA preparation. This genomic
DNA preparation serves as a universal PCR template and can be
prepared from any tissue including peripheral blood cells. As for
now, several human and mouse cDNAs have been cloned in our
laboratories from a human genomic DNA template and a mouse
genomic DNA template respectively, and here we take the
multiple-exon human polymeric immunoglobulin receptor (PIGR)
gene as an example to illustrate this novel cDNA cloning strategy.
MATERIALS AND METHODS
Chemicals, enzymes and stains
Taq DNA polymerase, T4 DNA ligase, DL2000 DNA marker,
Blood Genome DNA Extraction Kit, and restriction endonu-
cleases were purchased from Takara Biotech Co., Ltd. (Dalian,
China). Phusion high-fidelity DNA polymerase and T7 endonu-
clease I were from New England Biolabs, Inc. (Ipswich, MA).
IPTG, X-Gal, and other chemicals were from Sigma-Aldrich, Inc.
(St Louis, MO). Oligonucleotides were synthesized and purified by
polyacrylamide gel electrophoresis by AuGCT Biotech Co., Ltd.
(Beijing, China). TA cloning vector (pGEMH-T easy vector) was
purchased from Promega Biotech Co., Ltd (Madison, WI). DH5a
competent cells were from Tiangen Biotech Co., Ltd (Beijing,
China). Glass milk DNA purification kits were from BioDev-Tech
Co., Ltd (Beijing, China).
Experimental design
The principle of this strategy is composed of three steps (Figure 1): i)
Amplification of all the exons of the desired gene with optimized
primers within flanking introns. ii) Joining of exons by overlapping
PCR. iii) Amplification of full-length products. The rationale of this
strategy is as follows: All the exon sequences of a gene exist in the
genome. But due to the low copy number (usually only one copy per
genome) of every exon and the extremely high complexity of the
genome, it is usually impossible to successfully amplify the full-length
cDNA sequence by overlapping primers located at the precise
splicing sites which are not possible for software optimization.
However, it is always easy to obtain any single exon (usually together
with some flanking intron sequences) from a genomic DNA
preparation by PCR with software-optimized, highly efficient
primers located in flanking introns. Then, by assembling the above
exons with deliberately designed overlapping primers, it is easy to
amplify the full-length cDNA or ORF of interest with software-
optimized, highly efficient outmost primers.
Preparation of universal genomic DNA template
A two hundred microliter whole blood sample was collected from
a healthy donor and the genomic DNA was extracted with Blood
Genome DNA Extraction Kit (Takara) according to the manufac-
turer’s instructions. The purified DNA was dissolved in 50 ml TE
buffer (10 mMTrisNCl, pH 8.0, 1 mMEDTA) and its concentration
was determined by an ultraviolet spectrophotometer (Milton Roy
Spectronic 601, Bio-Rad Laboratories, Inc., Richmond, CA).
Exon amplification and assembly
Exon amplification was performed in individual tubes on
a GeneAmp PCR system 2400 (Perkin Elmer, Foster City, CA).
For each exon, a standard PCR was carried out with 25 ml total
reaction mixture containing 50 mM KCl, 10 mM Tris-Cl,
1.5 mM MgCl2, 10 ng genomic DNA, 0.2 mM dNTP, 1 mM of
each forward and reverse primer, and 0.5 unit Taq polymerase.
The PCR parameters were as follows: pre-denaturation at 94uC
for 3 minutes, followed by 35 cycles of denaturation at 94uC for
30 seconds, annealing at 55uC for 30 seconds, and polymerization
at 72uC for 60 seconds, and a final incubation for 5 min at 72uC.
The PCR products were pooled and used as a template in the
subsequent overlapping PCR. In this second, overlapping PCR
reaction, the overlapping PCR primer pairs of all the exons and
the outmost primers (0.1 mM each) were pooled and used in
a 25 ml reaction mixture containing 2 ml of the pooled template
and the other components (see above). After 20 cycles of
amplification (denaturation at 94uC for 30 seconds, annealing at
55uC for 30 seconds, and polymerization at 72uC for 120 sec-
Figure 1. Schematic diagram of PCR mediated Genomic DNA Splicing (GDS) strategy. Individual exons are amplified in the first PCR (exon PCR)
following standard PCR protocol with software-optimized primers. A second PCR (overlapping PCR) is then carried out to join the exons and produce
the full-length coding sequence. ATG and TAG indicate the start and stop codons, respectively.
doi:10.1371/journal.pone.0001179.g001
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onds), 2 ml of the product was transferred into the final
amplification tube with a total volume of 50 ml containing the
other components as above and with the outmost primers to
amplify the full-length ORF sequence following a standard PCR
protocol. The PCR products were subjected to 1% agarose gel
electrophoresis and the gel containing full-length DNA was excised
and the DNA was purified with a glass milk kit (BioDev-Tech).
PCR with the Phusion high-fidelity DNA polymerase
When the Phusion high-fidelity DNA polymerase was used in place
of Taq polymerase, the thermocycle parameters were adjusted as
follows: pre-denaturation at 98uC for 30 seconds, denaturation at
98uC for 15 seconds, and annealing at 60uC for 30 seconds, with
other parameters unchanged. To add an A base at the 39 terminus,
the full-length PCR products were purified by extraction with equal
volume phenol-chloroform-isoamyl alcohol (25:24:1) and precipita-
tion with three volume ethanol. The DNA pellet was dissolved in
50 ml standard PCR reaction mixture (components see above,
without primers) containing 1 unit Taq DNA polymerase. After
incubation at 72uC for 20 minutes, the DNA was separated by 1%
agarose gel electrophoresis and the full-length DNA was purified
from the gel with a glass milk kit (BioDev-Tech).
T7 endonuclease I treatment of PCR products
The 39 A tailed DNA products amplified by the Phusion high-
fidelity DNA polymerase from two PCR reactions were dissolved
in 15 ml distilled water and subjected to denaturation at 98uC for
1 minute, and then a stepwise annealing procedure was carried
out as follows: 2 minutes at 85uC, 3 minutes at 75uC, 3 minutes at
65uC, 3 minutes at 37uC, followed by 3 minutes at room
temperature. The T7 endonuclease I treatment was performed
in a 20 ml solution containing the above DNA and 15 units of T7
endonuclease I as well as 16T7 endonuclease I buffer. The
mixture was incubated at 37uC for 1 hour to allow the
mismatched molecules to be cleaved by the T7 endonuclease I.
Cloning and sequencing
The PCR products generated by Taq DNA polymerase or 39 A
tailed PCR products generated by the Phusion high-fidelity DNA
polymerase were ligated with pGEMH-T easy vector (Promega).
The ligation mixture was transformed into DH5a competent cells
(Tiangen) and white colonies were picked and insertion was
analyzed by PCR and restriction enzyme cleavage. Positive clones
were subjected to DNA sequencing using an automated DNA
sequencer ABI377 (Perkin Elmer).
RESULTS
Exon Primer Design
An online program EasyExonPrimer [21] (http://129.43.22.27/
,primer/EasyExonPrimer.html), which is a free Internet service
hosted by NCI, was used to design the exon amplification primers
for the first round PCR. The human PIGR mRNA in NCBI
GenBank database was retrieved, and the GenBank accession
number as NM_002644 was obtained and submitted using this
program. Default parameters were used for primer selection, i.e.:
an optimal primer size of 22nt (18,25 nt); an optimal Tm of 60uC
(45uC,65uC); an optimal primer GC percentage of 45
(30%,60%); an optimal product Tm of 60uC (45uC,65uC);
a maximal self-complementarity of 8bp; and a maximal 39 self-
complementarity of 3bp. Exon 1 does not contain any coding
sequence, and is excluded from amplification. Since exon 11 is
longer than 1000 bp, which may make it difficult to be amplified,
this exon sequence was broken into several smaller fragments for
primer design. Only the first fragment of exon 11 contains coding
sequence, thus only the primer pairs for this fragment were
synthesized along with the primers of exon 2 though 10. The
relative primer positions are represented in Figure 2A and the
primer sequences are listed in Table 1.
Overlapping primer and outmost primer design
Overlapping primers were manually designed at the exon-exon
joining sites. To avoid a mismatch caused by an additional A base at
the 39 end produced by Taq polymerase, all the overlapping primers
start after a T base. Other considerations for the overlapping primer
design were no 39 self-pairing and low 39G/C content. The length of
the overlapping primers varied from 27 bp to 39 bp, with a minimal
overlapping region of 15 bases. The outmost primers (OL2F and
OL11R) for the full-length ORF amplification do not contain any
overlapping sequence and were selected using computer software
(Oligo version 6.71, Molecular Biology Insights, Inc., Cascade, CO).
The positions of the overlapping primers and the outmost primers
are illustrated in Figure 2B and their sequences are shown in table 1.
Figure 2C shows alignment of the overlapping primers and the
outmost primers with the PIGR coding sequence.
Amplification of PIGR coding exons by standard PCR
A genomic DNA preparation was made from a blood sample of
a healthy donor and was used as a universal exon PCR template.
Since exon 1 and majority of exon 11 of PIGR gene do not contain
any coding sequence, we only amplified exon 2 though 10 and the
first fragment of exon 11, using a standard PCR protocol. In order
to test the possibility of multiple exon assembly, we just used
ordinary Taq DNA polymerase to perform the PCRs. Without
any optimization of the PCR conditions, all of the exon PCRs
were successful as demonstrated by 1% agarose gel electrophoresis
(Figure 3A). The predicted length of exon 2 through exon 11 are
400 bp, 795 bp, 989 bp, 599 bp, 855 bp, 486 bp, 395 bp, 387 bp,
369 bp, 461 bp (fragment 1), respectively.
Assembly of full-length PIGR ORF by overlapping
PCR
The above exon PCR products were pooled without purification
and used as templates for a second round overlapping PCR to
assemble the full-length PIGR coding sequence. To amplify the
full-length PCR product, the outmost primers OL2F and OL11R
were used to perform another round standard PCR. Agarose gel
electrophoresis analysis of the final PCR product showed that
dominant amplification product was a ,2500 bp band (2295 bp
PIGR ORF plus two short flanking sequences) (Figure 3B). To
simplify the full-length product amplification, we tried to combine
the 20-cycle overlapping PCR and the final PCR by running only
a single PCR step with normal amount of outmost primers and
reduced amount of overlapping primers (each overlapping primer
concentration equals one-fiftieth of the outmost primer concen-
tration). We found this simplified protocol could amplify the full-
length product, but with a reduced amount of final product.
Sequence analysis of PIGR cDNA clones
We cloned the full-length PIGR coding sequence into pGEMH-T
Easy Vector. Five clones were picked up for DNA sequencing
analysis and the results showed that all 5 clones contained
correctly joined full-length PIGR coding sequence (Figure 3C), and
since we used the error-prone Taq DNA polymerase in the above
PCRs, there were an average of 2.5 point mutations per clone (the
Genomic DNA Splicing
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mutation rate is about 0.1%). Of all these mutations, nearly half
located within the overlapping primers. Since the overlapping
primers only compose a small fraction (much less than 50%) of the
whole sequence, it suggests that synthetic oligonucleotides have
a relatively high error rate[10,11]. One of the clones had only two
silent mutations and thus encoded wild type human polymeric
immunoglobulin receptor (Figure 3C).
Cloning of wild type cDNA with a high-fidelity
thermostable DNA polymerase
In many cases wild type DNA sequences are required. In order to
get wild type cDNA sequence, we then used the high-fidelity
thermostable DNA polymerase Phusion DNA polymerase (New
England Biolabs) to amplify the target DNA sequence in place of
error-prone Taq polymerase. We sequenced three clones derived
from Phusion DNA polymerase amplification and found two of
them had the wild type sequence. But the other clone still
contained a point mutation (G/A transition) at the location of the
overlapping primer Ex3R (the mutation rate is about 0.01%)
(Figure 3C). To further improve the method to get rid of possible
point mutations, we applied T7 endonuclease I (New England
Biolabs) to pre-treat the annealed full length PCR products before
ligation into pGEMH-T Easy Vector. Since T7 endonuclease I
hydrolyze the loop formed by mismatch between the mutant
strand and the wide strand, it can prevent the error PCR products
from ligation with T vectors. After transformation of the above
ligation mixture, three positive clones were subjected to DNA
sequencing. The results showed that all the three clones contained
correctly assembled, full-length wild type PIGR coding sequence.
Similarly, we have cloned full-length coding sequences of
human immunoglobulin J polypeptide gene (IGJ, NM_144646,
480 bp), human high-mobility group box 1 gene (HMGB1,
NM_002128, 612 bp) and mouse urokinase-type plasminogen
activator gene (uPA, NM_008873, 1302 bp). These successful
cloning experiments suggest that our ‘‘Genomic DNA Splicing’’
technique is reliable and practicable.
Figure 2. Primer design for PIGR ORF cloning by GDS strategy. A. Exon primers for exon PCRs. All exons are represented by solid arrows and are
flanked by optimized forward and reverse primers located in introns. The start codon resides in exon 2 and stop codon in exon 11. Exon 1 does not
contain a coding sequence and was not amplified. For exon 11, only the region containing the coding sequence was amplified. B. Overlapping
primers for overlapping PCR. C. Alignment of the overlapping primers with the cDNA sequence (only a portion is shown). Primers are boxed and their
orientations are indicated by parallel arrows. Exon-exon junctions are marked by vertical lines.
doi:10.1371/journal.pone.0001179.g002
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PLoS ONE | www.plosone.org 4 November 2007 | Issue 11 | e1179
DISCUSSION
PCR-based de novo gene synthesis is now frequently used in
molecular biology laboratories worldwide, with the free online
tools to automate the primer design and, more importantly, to
optimize the codon usage for efficient expression in intended
organism, such as for E.coli or yeast expression [12,20]. However,
this gene synthesis strategy (known as ‘‘assembly PCR’’) requires
large amounts of chemically synthesized oligonucleotides, multiple
rounds of PCRs, and often results in numerous unwanted point
mutations due to the large number of synthesized bases and
multiple rounds of PCRs[10,11].
Here we reported a new gene synthesis strategy, ‘‘PCR
mediated Genomic DNA Splicing’’ (GDS), which resembles
‘‘assembly PCR’’ in procedures but takes advantage of genomic
DNA to avoid synthesis of large amount of oligonucleotides, thus is
cost-effective and can reduce the unwanted mutations introduced
by chemical synthesis of large numbers of relatively long
oligonucleotides[10]. In the case of PIGR ORF (2549 bp) cloning,
if the ‘‘assembly PCR’’ method had been used, we had to
synthesize about 5000 bases, and all of them would contribute to
the final sequence. When the GDS method was used, only 1058
bases were synthesized, and among them, only 549 bases (less than
one-ninth of the ‘‘assembly PCR’’) contributed to the final
sequence. It has been reported that assembly PCR results in
a point mutation rate of 0.1% even when the proof reading
thermostable DNA polymerase Pfu was used [11]. In our previous
assembly PCR experiment using Taq polymerase, which is error-
prone, we found an average of 3 point mutations in a 720bp de novo
synthesized sequence (the mutation rate was 0.4%) [22]. However
when we used the Taq polymerase to perform GDS cloning, the
mutation rate was only about 0.1%.
In order to enhance the fidelity of our method and get wild type
sequences, we tried to apply a high-fidelity thermostable DNA
polymerase (namely Phusion high-fidelity DNA polymerase) for
the PCRs. Since this DNA polymerase possesses a 39-59 proof-
reading endonuclease activity, its mutation rate is 50-fold lower
than that of Taq DNA polymerase and 6-fold lower than that of
Pyrococcus furiosus (Pfu) DNA polymerase (as claimed by the
manufacturer). To further reduce the mutation rate, we employed
the T7 endonuclease I to cleave the mismatched loop formed
between the mutated sequence and the wild type sequence after
the PCR products were denatured and then annealed. Our results
showed that the mutation rate was reduced to about 0.01% when
the Phusion high-fidelity DNA polymerase was used alone, and no
point mutation was identified when the T7 endonuclease I was
used as a combination with Phusion high-fidelity DNA poly-
merase. For the 2549 bp DNA sequence cloned in this report, wild
type sequences were obtained in both experiments with the high-
fidelity DNA polymerase.
One advantage of the cDNA cloning strategy described in this
report is that neither RNA extraction nor reverse transcription is
needed, and thus it saves the costs of RNA extraction kits and cDNA
synthesis kits. The second advantage is that it is not necessary to
handle any specific tissues for a particular gene and the expression
level of the gene is not a problem. The third advantage is that high
fidelity DNA sequence is obtained with high efficiency while the
process is simple and easy. The entire assembly process takes only
a few hours.We found that even if some of the first round PCRs were
Table 1. Primer sequences.
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Exon Primers (59----39)
Forward Reverse
Exon2 Ex2F GTTATGGAAAAAGTGGAGGCAC Ex2R TCTTCTCTGTATGACTCTTCCTCAA
Exon3 Ex3F CCCTTGTCCTTGAAATGGTTATC Ex3R GTTATAGGCCACCAAGTCCTAGAAG
Exon4 Ex4F GAAGGAGGGCATTCCAGGTTAT Ex4R AGAGTAATTAGGAGCTGCCATCAG
Exon5 Ex5F AAGGTGATGCGTGTAAACTTCA Ex5R AATGTGACCTCTGGATAGGTGG
Exon6 Ex6F TCCATGTGTGAAGATCTATGGTCTA Ex6R ACTCTCCACTTTCAGCCTCTTACAG
Exon7 Ex7F CATCACAGCTGTTTCTAATGTCATC Ex7R CCTCCCACATATAAGCAGAGGTAGT
Exon8 Ex8F TCTTAGAAGAACAGAGCTAGGGAGC Ex8R CTTTCTCGGGATCCTTTGTTTTAG
Exon9 Ex9F CATAGTCAGAGCTGCACCACCT Ex9R GCAACAAACTCTGTGTGAAGAAAG
Exon10 Ex10F GAAAAGAAGGTATGACCCTCACTC Ex10R GCATCCCACAACCAGTAAGATATAG
Exon11 Ex11F GTCAGAAGGAGGTAGTGAGACAGAA Ex11R CTCTGAGGACAGTAGGAAAAACCTA
Overlapping Primers (59----39)
Forward Reverse
Exon2 OL2F CAAAGCCAAATAGATGTC OL2R CGTGGAGATGGCTGGGAAGACCGCCAGCA
Exon3 OL3F CTTCCCAGCCATCTCCACGAAGAGTCC CATA OL3R AGGAGCCCAGGACCCTGGCTGACCTCCAGG
CTGA
Exon4 OL4F CAGCCAGGGTCCTGGGCTCCTAAATGA OL4R CGTGGACTCCTCATTGACGAAGAGTTG
Exon5 OL5F CGTCAATGAGGAGTCCACGATTCCCCG CA OL5R TTGGTTCTCCTTCGATAATCTTGATCT
Exon6 OL6F TATCGAAGGAGAACCAAACCTCAAGGTA OL6R CGCGGGACCCCGCTGCCTTCCTCTCTTCAA
Exon7 OL7F AAGAGAGGAAGGCAGCGGGGTCC CGCGATGTCAGCCTA OL7R GTTCCTCAGAGCTGCCGGAATCCACAGAT
Exon8 OL8F TCCGGCAGCTCTGAGGAACAAGGTGGAA OL8R CTGATTGAAACTCGGTCGACGTTCTTCCTGTG
Exon9 OL9F CGACCGAGTTTCAATCAGAAGCTACA OL9R GGCAACAAACTCTTCTTTTCCTCCGAGGGATGT
Exon10 OL10F CGGAGGAAAAGAAGAGTTTGTTGCCA CCACTGA OL10R CGGCTTCCTCCTTGGATGACCTTTTTGCCT TCTTGGGTT
Exon11 OL11F CATCCAAGGAGGAAGCCGAGAT OL11R CCTAGGCAGGTGTTAGAG
doi:10.1371/journal.pone.0001179.t001..
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not very successful (PCR product bands were not visible in ethidium
bromide stained agarose gel), it usually did not affect the final full-
length DNA amplification. So it is usually not necessary to optimize
PCR conditions even if one or more exon primer pairs do not work
very well in the first round PCR.
In order to make the primer design easy, we searched the
Internet for appropriate programs to automatically design exon
amplification primers, and found a few useful applications,
including Genomic Primers (http://www2.eur.nl/fgg/kgen/prim-
er/Genomic_Primers.html), ELXR (http://ecom2.mwgdna.com/
services/elxr/elxrdb_query.tcl?loc =EBE) [23], ampExon (http://
bioinformatics.well.ox.ac.uk/mst-bin/ampexon.pl), ExonPrimer
(http://ihg.gsf.de/ihg/ExonPrimer.html), and EasyExonPrimer
[21] (http://129.43.22.27/,primer/EasyExonPrimer.html). We
chose to use EasyExonPrimer because it is highly automatic, very
easy to use and free for use. This online tool is written in PERL and
is based on a common PCR primer design program Primer3. We
found that this online tool produced very efficient primers for exon
amplification. All of our exon primers are designed by this software
and almost all of them have successfully amplified the target
sequences, including the exons of human PIGR, IGJ, HMGB1 and
mouse uPA genes, without PCR condition optimization. To design
the exon-exon junction primers (overlapping primers, or splicing
primers), we could not find any appropriate program. We tried to
use an online application ExPrimer [24], which is a web based
computer program to design primers from exon-exon junctions of
a specific gene transcript, but the output exon-exon junction
primers need to be paired by other primers located in exons, and
these primers are not suitable for overlapping PCR. So we just
designed all of our overlapping primers manually.
As for our knowledge, this is the first report of a rapid and
efficient method to clone wild type multiple-exon cDNA sequences
directly from a single genomic DNA preparation. Lebedenko et al
reported an in vitro exon ligation method, but it involved
complicated steps including two-step PCR to amplify the exons,
cloning of all exons separately, introduction of specific restriction
enzymes and ligation of multiple restriction fragments[25]. A
similar PCR-based exon ligation method was proposed by
Vandenbroeck et al, which required multiple rounds of PCR and
multiple ligation reactions of blunt-end PCR products and
restriction fragments[26]. Chistiakov et al used a PCR procedure
to assemble exons of human interleukin 1 gene, but the exons were
obtained from cloned DNA and only 3 exons were assembled by
two rounds overlapping PCR, with each round of PCR to join
Figure 3. Amplification, assembly and cloning of PIGR coding sequence by GDS strategy. A. Amplification of PIGR coding exons by standard PCR
protocol with exon primers. The sizes of the amplified fragments of exon 2 through 11 are 400 bp, 795 bp, 989 bp, 599 bp, 855 bp, 486 bp, 395 bp,
387 bp, 369 bp, 461 bp, respectively. B. Amplification of full-length PIGR coding sequence. The size of the amplified full-length sequence is 2549 bp,
including 2295 bp PIGR ORF and two short flanking sequences. C. Exon assembly of PIGR coding sequence. The start and stop codons are boxed.
Exon-exon junctions are marked by vertical lines. The point mutations mentioned in the text are indicated by the mutated bases in parenthesis under
the wild type ones. DL2000, DNA molecular weight marker (Takara).
doi:10.1371/journal.pone.0001179.g003
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only two exons (exon 5 and 6 were joined first, and then exon 5+6
was joined with exon 7)[27].
Thus we have developed a time- and cost-effective method for
multiple-exon cDNA or ORF cloning directly from genomic
DNA, which does not require tissue handling, RNA preparation
and reverse transcription, and efficiently produces wild type full-
length cDNA or ORF sequences.
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